| Page | |
|---|---|
| Report ofthe Trustees and Strategic Report | 1 — 11 |
| Report ofthe Independent Auditors | 12— 15 |
| Statementof Financial Activities | 16 |
| Balance Sheet | 17 |
| Cash Flow Statement | 18 |
| Notes to the Cash Flow Statement | 19 |
| Notes to the Financial Statements | 20—27 |
| Trustees | |
|---|---|
| Mr C Barratt | Chair ofTrustees & Chair of Finance and Audit Committee |
| Ms C Dodwell | Deputy Chair and Chair of the Capital Developments Committee |
| Mr C Bridge | Chair of the Integrated Governance Committee |
| Mr RG Hammond | Chair of the Workforce and Remuneration Committee |
| Dr C S Ince | |
| Mr L Marlow | Chair of the Finance and Audit Committee |
| Ms S Watson | |
| Mr N Smillie | Appointed August2019 |
| Mr A Appleton | Appointed April 2020 |
| Mr MRPA Manning | Appointed December2020 |
| Mr Suriwala | Resigned December2020 |
| Key Management Personnel: | |
| Ms C Nolan | |
| Chief Executive Officer |
fthegovernancefr n them: |
a | mework. In total t | here are five Boa | rd committees an | d these are the Di | rectorswho serv |
|---|---|---|---|---|---|---|
| I | Director | Integrated | Finance and | Capital | Workforce | |
| Committees | Appointments | Governance | Audit | Development | and Remuneration |
|
| Mr C Barratt | Chair | x | x | x | ||
| Mr C Bridge | Chair | X | ||||
| Ms C Dodwell | Chair | |||||
| Mr R G Hammond | X | X | Chair | |||
| DrCSlnce | X | x | ||||
| Mr L Marlow | Chair | X | x | |||
| Ms S Watson | x | |||||
| Mr N Smillie | x | |||||
| MrA Appleton | X |
23rd September 2021
| 2020 | 2019 | ||
|---|---|---|---|
| Unrestricted | Unrestricted | ||
| funds | funds | ||
| £ | £ | ||
| Notes | |||
| INCOME | |||
| Donations and legacies Investmentincome |
3 4 |
- - |
1,150 325 |
| Incoming resources from charitable activities Medical services provided Other income |
5 | 9826,734 64387 |
13,953,947 11,294 |
| Total income | 9,891,121 | 13,966,716 | |
| EXPENDITURE | |||
| Charitable activities | |||
| Medical services provided | 6 | 10,797,843 | 13930,820 |
| Total expenditure | 10,797,843 | 13930,820 | |
| NET (EXPENDITURE)IINCOME | (906,722) | 35,896 | |
| Total funds broughtforward | 12,996,862 | 12,960,966 | |
| TOTAL FUNDS CARRIED FORWARD | 12,090,140 | 12,996,862 |
| 2020 | 2019 | |||
|---|---|---|---|---|
| Unrestricted | Unrestricted | |||
| funds | funds | |||
| Notes | £ | £ | ||
| FIXED ASSETS | ||||
| Intangible assets Tangible assets Total Fixed Assets |
13 14 |
26,076 12,423204 12,449,280 |
35568 12,808,865 12,844,433 |
|
| CURRENTASSETS Stocks Debtors: amounts falling due within one year Cashatbank |
15 16 |
353,188 1,236,656 522,172 |
324,108 1,264,410 748,041 |
|
| 2,112,016 | 2,336,559 | |||
| CREDITORS | ||||
| Amounts falling due within one year | 17 | (1,080,956) | (1,393930) | |
| NET CURRENT ASSETS | 1,031,060 | 942,629 | ||
| TOTAL ASSETS LESS CURRENT LIABILITIES | 13,480,340 | 13,787,062 | ||
| CREDITORS | ||||
| Amounts falling due aftermore than one year | 18 | (1,390,200) | (790,200) | |
| NET ASSETS | - | 12,090,140 | 12,996,862 | |
| FUNOS Unrestricted funds |
20 | 12,090,140 | 12,996,862 | |
| TOTAL FUNDS | 12,090,140 | 12,996862 |
| 2020 | 2019 | ||
|---|---|---|---|
| Notes | £ | £ | |
| Cash flow from operating activities | |||
| Netcash (used in)/provided by operating activities | I | (597241) | 699830 |
| Cash flows from investing activities Purchaseofintangibleassets Purchase ofproperty, plant and equipment Interest received |
(7936) (220,692) - |
(23,082) (320,774) 325 |
|
| Net cash used in investing activities | (228,628) | (343,531) | |
| Cash flows from financing activities | |||
| Loan drawn down in year | 600,000 | - | |
| Net cash from investing activities | 600,000 | ||
| Change in cash and cash equivalents in the reporting period | (225,869) | 356,299 | |
| Cash and cash equivalents at the beginning of the reporting | 748,041 | 391,742 | |
| period | |||
| Cash and cash equivalents at the end of the reporting | 2 | 522,172 | 748,041 |
| period |
| RECONCILIATION OF NET INCOME TO NET CASH INFLOW | FROM OPERATI | NG ACTIVIT | |
|---|---|---|---|
| 2020 | 2019 | ||
| £ | £ | ||
| Net (expenditure)Iincomefor reporting period (as perthe | (906,722) | 35896 | |
| statement offinancial activities) Amortisation ofintangible assets Depreciation charges Interest received |
17,428 530,537 - |
21,929 491,682 (325) |
|
| (Increase)/decrease in stocks Decrease/(increase) in debtors (Decrease)/increase in creditors |
(29,080) 27,369 (236773) |
11,845 (65817) 204,620 |
|
| Net cash provided by operating activities | (597,241) | 699,830 | |
| 2. | ANALYSIS OF CASH AND CASH EQUIVALENTS | ||
| 2020 | 2019 | ||
| £ | £ | ||
| Cash | 522,172 | 748,041 |
| NALYSIS OF CHANGES IN NET DEBT | |||
|---|---|---|---|
| At | At31 | ||
| 1 January | Cash flow | December | |
| 2020 | 2020 | ||
| £ | £ | £ | |
| Net cash: | |||
| Cash at bank | 748,041 | (225,869) | 522,172 |
| Bank Loan due in greater than one year | (600,000) | (600,000) | |
| 748,041 | (825,869) | (77,828) |
| 3. | DONATIONS AND LEGACIES | ||
|---|---|---|---|
| 2020 | 2019 | ||
| £ | £ | ||
| Legacies and Donations | - | 1,150 | |
| 4. | INVESTMENT INCOME | ||
| 2020 | 2019 | ||
| £ | £ | ||
| Bank interest | - | 325 |
| 2020 | 2019 | |||
|---|---|---|---|---|
| £ | £ | |||
| Medical | services | provided | 9,826,734 | 13,953,947 |
| Direct Medical | Supportcosts | Governance | Total | Total | |
|---|---|---|---|---|---|
| costs | (see note 12) | Costs (see | 2020 | 2019 | |
| (see note 7) £ |
£ | £ note 8) |
£ | £ | |
| Medical services | 7,645,390 | 3,131,573 | 20,880 | 10,797,843 | 13,930,820 |
| Provided |
| DIRECT COSTS OF CHARITABLE ACTIVITIES | ||
|---|---|---|
| 2020 | 2019 | |
| £ | £ | |
| Staffcosts | 2,871,466 | 2,613,604 |
| Direct medical costs | 4,051,503 | 7,163,392 |
| Insurance | 333,167 | 267,707 |
| Patient services | 111,108 | 139,113 |
| Medical Equipment Maintenance and Repair | 278,146 7,645,390 |
308,280 10,492,096 |
| 8. | GOVERNANCE COSTS | ||
|---|---|---|---|
| 2020 | 2019 | ||
| £ | £ | ||
| Auditors’ remuneration | 20,880 | 16,680 | |
| 9. | NET (EXPENOITLJRE)IINCOME | ||
| Net (experiditure)/iricome is stated afterchargirtg/(crediting): | |||
| 2020 | 2019 | ||
| £ | £ | ||
| Auditor’s remuneration | 20,880 | 16,680 | |
| Amortisation of intangibleassets Depreciation of owned assets |
17,428 530,537 |
21929 491,682 |
| STAFF COSTS AND THE COST OF KEY MANAGEME | NT PERSONNEL | |
|---|---|---|
| 2020 | 2019 | |
| £ | £ | |
| Salaries and wages: - Nursing and otherclinical staff - Housekeeping, catering and maintenance • Management and administration |
2,509,237 509,638 1,163,997 4,182,872 |
2,553798 515923 1,154994 4,224,715 |
| Wage and salaries Social security costs Pension costs |
3,781420 305739 95,713 |
3839,485 297,153 88,077 |
| 4,182,872 | 4,224,715 |
| ithin the foll | owing range |
|---|---|
| 2020 | 2019 |
| Number | Number |
| 1 | 1 |
| Average number employed (including temporary staf | f): | |
|---|---|---|
| 2020 | 2019 | |
| Nursing and other clinical Management, clerical and domestic |
112 95 207 |
110 95 205 |
| Support costs incurred in the year in relation t | o charitable activities were as follo | ws: |
|---|---|---|
| 2020 | 2019 | |
| £ | £ | |
| Management Finance |
1,813,105 70,490 |
2,156,060 53,935 |
| Information Technology Property |
305,652 942,327 3,131,573 |
278,499 933,550 3,422,044 |
| INTANGIBLE FIXED ASSETS | |
|---|---|
| Total | |
| Software | |
| £ | |
| COST | |
| Ati January2020 | 110,567 |
| Additions | 7936 |
| At31 December2020 | 118503 |
| DEPRECIATION | |
| At 1 January 2020 Charge for year |
74999 17,428 |
| At 31 December2020 | 92,427 |
| NET BOOK VALUE | |
| At 31 December2020 | 26076 |
| At31 December2019 | 35568 |
| TANGIBLE FIXED ASSETS | ||||
|---|---|---|---|---|
| Medical | ||||
| Equipment, | ||||
| Freehold land |
Freehold property |
Fixtures, Fittings, |
T I o a |
|
| Computer | ||||
| Equipment | ||||
| £ | £ | £ | £ | |
| COST | ||||
| At 1 January 2020 Additions |
3,366,366 - |
8,796202 10116 |
3,163,026 134,760 |
15,325594 144876 |
| At 31 December 2020 | 3366366 | 8806,318 | 3,297,786 | 15470,470 |
| DEPRECIATION | ||||
| At 1 January 2020 Chargeforyear |
- - |
1,010,572 178,440 |
1,506,157 352,097 |
2516729 530,537 |
| At 31 December 2020 | - | 1189,012 | 1,858,254 | 3047266 |
| NET BOOK VALUE | ||||
| At 31 December 2020 At 31 December 2019 |
3.366.366 3.366366 |
Z&3L LZ |
J22 | J2Q 12.808.865 |
| STOCKS | ||||
|---|---|---|---|---|
| 2020 | 2019 | |||
| £ | £ | |||
| Consumable Pharmacy |
medical | supplies | 326,910 26278 353,188 |
304,059 20,049 324,108 |
| 16. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||
|---|---|---|---|
| 2020 | 2019 | ||
| £ | £ | ||
| Trade debtors | 872562 | 1012375 | |
| Prepayments and accrued income | 364094 1236656 |
252035 1264410 |
|
| 17. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||
| 2020 | 2019 | ||
| £ | £ | ||
| Trade creditors | 498,915 | 846,280 | |
| Social security and othertaxes Accruals and deferred income |
95,807 486,234 |
94,844 452,806 |
|
| 1080,956 | 1.393930 |
| 2020 | 2019 | ||
|---|---|---|---|
| £ | £ | ||
| CBILS Lease |
Loan (Note 19) deposits |
600,000 790,200 1,390,200 |
- 790,200 790200 |
| OVEMENT IN | FUNDS | ||||||
|---|---|---|---|---|---|---|---|
| At January 2020 |
Incoming Resources |
Resources Expended |
Funds transferred |
Gains and Losses |
At December 2020 |
||
| £ | £ | £ | £ | £ | £ | ||
| Unrestricted | |||||||
| funds Generalfund Total Funds |
12,996,862 12,996862 |
9,891,121 9,891121 |
(10,797843) (10.797,843) |
- | - - |
12,090,140 12,090,140 |
| ANALYSIS OF RESERVES | ||
|---|---|---|
| 2020 | 2019 | |
| £ | £ | |
| Total reserves | 12,090,140 | 12,996,862 |
| Less: Land and buildings | (10,406,598) | (11,151,996) |
| Add: Lease deposits relating to land and buildings Freely available reserves |
790200 2,473742 |
790200 2,635,066 |
| FINANCIAL INSTRUMENTS | ||
| 2020 | 2019 | |
| £ | £ | |
| Financial assets measured atamortised cost | 1,428476 | 1,760,416 |
| Financial liabilities measured at amortised cost | 1,889,115 | 1,636,480 |